中/EN Contact/Message
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • 中/EN
  • Contact/Message
    • Innovate
    Your current position：
    OMLONTI (omidenepag isopropyl ophthalmic solution) 0.002%
    OMLONTI (omidenepag isopropyl ophthalmic solution) 0.002%
    departments：眼科
    drug：眼用制剂
    Active：oomidenepag isopropyl ophthalmic solution
    indication：降低开角青光眼或眼压患者的眼压升高
    Licensor：Santen, Inc.
    Approved Country/Region：FDA
    Approval time：2022-09-22